Original filing (PDF)20250625000457NAL0017678258001

PROCELL THERAPIES, LLC

Name: PROCELL THERAPIES, LLC — PROCELL 401(K) PLAN, Form 5500 (2024)
Creator: PROCELL THERAPIES, LLC

Form 5500-SF

FILING_RECEIVED

PROCELL 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$169K

Net assets (EOY)

$169K

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for PROCELL THERAPIES, LLC.

Plan sponsor

Name

PROCELL THERAPIES, LLC

EIN

47-1192558all filings

Address

1920 E RIVERSIDE DR · STE A 120 PMB 287 · AUSTIN, TX · 78741

Phone

(802) 999-2408

Industry

Wholesale Tradesee all

Plan administrator

Name

PROCELL THERAPIES, LLC

EIN

47-1192558

City

AUSTIN, TX

Phone

(802) 999-2408

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-06-25

Pension benefit codes

2A · Age/service weighted or new comparability

2E · Profit-sharing

3D · Pre-approved plan (master / prototype / VS)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2R · Participant-directed brokerage (SDBA)

2F · ERISA section 404(c)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

IWASE COSFA USA INC.

IWASE COSFA USA INC. 401(K) PLAN

$168K · 6 participants

ALGEN BIOTECHNOLOGIES, INC.

ALGEN BIOTECHNOLOGIES 401(K) PLAN

$168K · 8 participants

BOSTON NUTRACEUTICAL SCIENCE LLC

BOSTON NUTRACEUTICAL SCIENCE 401K

$168K · 20 participants

AVONDALE PHARMACEUTICALS LLC

AVONDALE PHARMACEUTICALS - 401(K)

$171K · 10 participants

COMPOUND PHARMACEUTICAL TECHNOLOGIES, INC.

COMPOUND PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PROFIT SHARING PLAN

Researching more plans? Run a Form 5500 search by company name, EIN, or plan name.